Get 50% OFF This Summer!
Mukka Proteins
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Mukka Proteins Ltd. was originally incorporated as 'Mukka Sea Food Industries', a Partnership firm in Karnataka on March 13, 2003. Subsequently, the Partnership Firm converted to Private Company as 'Mukka Sea Food Industries Private Limited' on November 04, 2010. The company was converted into Public Company dated December 02, 2019 in the name of 'Mukka Sea Food Industries Limited' and subsequently, company name changed to 'Mukka Proteins Limited' vide a fresh certificate of incorporation issued by ROC-Bangalore, dated August 06, 2021.
The Company is an animal protein company, primarily engaged in the production of Fish Meal, Fish Oil and Fish Soluble Paste as well as developing alternative proteins such as Black Soldier Fly (BSF) Insect meal in the animal food segment. It cater to the aquaculture sector which is the world's fastest-growing food sector. It is led by the Promoter, Mr. Kalandan Mohammed Haris.
Mukka Group is one of the pioneers in the Fishmeal Industry having set up one of India's first steam sterilised fishmeal plants. They produce Steam Dried Fish Meal, Fish Oil and Fish Soluble Paste from their modern and fully mechanized plant situated in Karnataka and Gujarat, which is geared up to deliver Fish Meal, Fish Oil and Fish Soluble Paste to every corner of the globe. Recently, the Company diversified products by developing alternative proteins such as Black Soldier Fly (BSF) Insect Meal and Insect Oil in the animal food industry.
The Company business is extended to manufacture of High-Quality Fish Meal and Omega-3 Fish Oil which is used as a raw material in aquafeed, poultry feed, pet feed, animal feed, EPA-DHA extraction (use in nutraceuticals - nutrients plus pharmaceuticals), soap manufacture, leather tanneries & Paint industries across globally.
In 2014, the Company commenced International operations in the Middle East.
In 2018, it set up a Manufacturing Facility in Gujarat.
A Joint Venture Agreement dated September 13, 2021 between Ento Proteins Private Limited (EPPL) and Holocene Ecosolutions Private Limited (HEPL) (a part of Sakku Group based in Guntur, Andhra Pradesh, one of the largest producers of BSF eggs in India was formed. With the formation of the Company, Ento Proteins Private Limited has converted around 4659 tons of food waste (wet waste) at the Municipal Solid Waste (MSW) site in the city of Mangalore through Black Soldier Fly Larvae (BSFL) which yielded around 400 Tons of BSF larvae to be used in producing alternative proteins in the animal protein segment by upcycling agri/food waste.
Mukka Proteins share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Mukka Proteins indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Mukka Proteins is valued compared to its competitors.
Mukka Proteins PE ratio helps investors understand what is the market value of each stock compared to Mukka Proteins 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Mukka Proteins evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Mukka Proteins generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Mukka Proteins in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Mukka Proteins shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Mukka Proteins compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Mukka Proteins over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Mukka Proteins helps investors get an insight into when they can enter or exit the stock. Key components of Mukka Proteins Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Mukka Proteins shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Mukka Proteins ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Mukka Proteins provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Mukka Proteins highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Mukka Proteins .
The balance sheet presents a snapshot of Mukka Proteins ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App